Application completed Purchase Marketing
페이지 정보

본문
Author information
Name | Anant Marathe |
---|---|
Phone number | 9198-2041-5197 |
maratheanant30@gmail.com |
Inquiry content
Dear Sir,
Warm Greetings from GUANGZHOU AANPHARM TECHNOLOGY CO., LTD!
Hope you are fine and doing well.
I'd like to introduce our Company to you.
We are a science-driven manufacturer & supplier. headquartered in Guangzhou, China, with 25 years of industry experience. Our organization is committed to advancing pharmaceutical innovation through reliable, scalable, and customized chemical manufacturing at GMP and ISO-compliant production sites with Integrated R&D and QA/QC labs.
Our intermediates are used in the synthesis of APIs for various therapeutic areas, including oncology, antivirals, anti-diabetics, cardiovascular, and CNS drugs.
We also cater to a range of industrial sectors through high-performance specialty chemicals.
We support CMC documents with Site Audit.
Please refer to our attached Company details and Products list.
We are interested in supplying you with the below Intermediates of Baricitinib API.
4-(4,4,5,5-Tetramethyl- 1,3,2-dioxaborolan-2-yl)- 1H-pyrazole CAS No. 269410-08-4.
2-( 1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile, CAS No. 1187595-85-2.
Baricitinib phosphate , CAS No. 1187595-84-1
You are requested to explore how we can collaborate, work together, and serve each other for better opportunities and growth.
You can directly contact the AANpharm , Contact Person - Linda, for any queries.
I would appreciate your support.
Thanks,
Anant Marathe – India Representative,
2/56, Ramanand Society, Subhash Road,
Vile-Parle (East), Mumbai - 400 057, India.
Cell / WhatsApp + 91 9820415197
For,
Linda
Guangzhou AANpharm technology co.,ltd
Address: Room 201, No.159 Jiangtong Road, Jianggao Town, Baiyun District,
Guangzhou, China.
Contact Person : Linda - WhatsApp +86-13925088720, Tel: 020-86211473
첨부파일
-
AANpharm Introduction Product List.pptx (692.1K)
0회 다운로드 | DATE : 2025-07-12 01:09:46
답변목록
There are no registered answers.
- Previous postSales Director & NBD 25.07.16
- Next postPharma intermediate manufacturer 25.07.11